ALT 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGPT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
≤ 11 12 11 12 O
2.5 13 16 13 16 B-upper_bound
x 17 18 17 18 I-upper_bound
institutional 19 32 19 32 I-upper_bound
upper 33 38 33 38 I-upper_bound
limit 39 44 39 44 I-upper_bound
of 45 47 45 47 I-upper_bound
normal 48 54 48 54 I-upper_bound
( 55 56 55 56 I-upper_bound
ULN 56 59 56 59 I-upper_bound
) 59 60 59 60 I-upper_bound
≤ 61 62 61 62 O
5 63 64 63 64 B-upper_bound
x 65 66 65 66 I-upper_bound
IULN 67 71 67 71 I-upper_bound
for 72 75 72 75 O
patients 76 84 76 84 O
with 85 89 85 89 O
liver 90 95 90 95 B-cancer
metastases 96 106 96 106 I-cancer

AST 0 3 107 110 B-clinical_variable
( 4 5 111 112 I-clinical_variable
SGOT 5 9 112 116 I-clinical_variable
) 9 10 116 117 I-clinical_variable
≤ 11 12 118 119 O
2.5 13 16 120 123 B-upper_bound
x 17 18 124 125 I-upper_bound
institutional 19 32 126 139 I-upper_bound
upper 33 38 140 145 I-upper_bound
limit 39 44 146 151 I-upper_bound
of 45 47 152 154 I-upper_bound
normal 48 54 155 161 I-upper_bound
( 55 56 162 163 O
IULN 56 60 163 167 B-clinical_variable
) 60 61 167 168 O
≤ 62 63 169 170 O
5 64 65 171 172 B-upper_bound
x 66 67 173 174 I-upper_bound
IULN 68 72 175 179 I-upper_bound
for 73 76 180 183 O
patients 77 85 184 192 O
with 86 90 193 197 O
liver 91 96 198 203 B-cancer
metastases 97 107 204 214 I-cancer

AST 0 3 215 218 B-clinical_variable
/ 3 4 218 219 I-clinical_variable
ALT 4 7 219 222 I-clinical_variable
≤ 8 9 223 224 O
2.5 10 13 225 228 B-upper_bound
x 14 15 229 230 O
the 16 19 231 234 O
IULN 20 24 235 239 O

Absolute 0 8 240 248 B-clinical_variable
neutrophil 9 19 249 259 I-clinical_variable
count 20 25 260 265 I-clinical_variable
( 26 27 266 267 I-clinical_variable
ANC 27 30 267 270 I-clinical_variable
) 30 31 270 271 I-clinical_variable
≥ 32 33 272 273 O
1500 34 38 274 278 B-lower_bound
, 38 39 278 279 O
platelets 40 49 280 289 B-clinical_variable
≥ 50 51 290 291 O
100,000 52 59 292 299 B-lower_bound
, 59 60 299 300 O
unless 61 67 301 307 O
due 68 71 308 311 O
to 72 74 312 314 O
direct 75 81 315 321 O
bone 82 86 322 326 B-chronic_disease
marrow 87 93 327 333 I-chronic_disease
involvement 94 105 334 345 I-chronic_disease
of 106 108 346 348 I-chronic_disease
disease 109 116 349 356 I-chronic_disease

Age 0 3 357 360 B-age
18 4 6 361 363 B-lower_bound
years 7 12 364 369 I-lower_bound
or 13 15 370 372 O
greater 16 23 373 380 O

Age 0 3 381 384 B-age
> 4 5 385 386 O
18 5 7 386 388 B-lower_bound
years 8 13 389 394 I-lower_bound

All 0 3 395 398 O
patients 4 12 399 407 O
must 13 17 408 412 O
have 18 22 413 417 O
measurable 23 33 418 428 O
disease 34 41 429 436 O
documented 42 52 437 447 O
by 53 55 448 450 O
CT 56 58 451 453 B-treatment
, 58 59 453 454 O
MRI 60 63 455 458 B-treatment
, 63 64 458 459 O
or 65 67 460 462 O
non 68 71 463 466 O
- 71 72 466 467 O
measurable 72 82 467 477 O
disease 83 90 478 485 O
documented 91 101 486 496 O
by 102 104 497 499 O
Physical 105 113 500 508 O
Exam 114 118 509 513 O
within 119 125 514 520 O
28 126 128 521 523 B-upper_bound
days 129 133 524 528 I-upper_bound
prior 134 139 529 534 I-upper_bound
to 140 142 535 537 O
registration 143 155 538 550 O

Baseline 0 8 551 559 B-treatment
( 9 10 560 561 I-treatment
pre 10 13 561 564 I-treatment
- 13 14 564 565 I-treatment
treatment 14 23 565 574 I-treatment
) 23 24 574 575 I-treatment
EKG 25 28 576 579 I-treatment
with 29 33 580 584 O
any 34 37 585 588 O
of 38 40 589 591 O
the 41 44 592 595 O
following 45 54 596 605 O
changes 55 62 606 613 O
consistent 63 73 614 624 O
with 74 78 625 629 O
cardiac 79 86 630 637 B-chronic_disease
ischemia 87 95 638 646 I-chronic_disease

Baseline 0 8 647 655 O
( 9 10 656 657 O
pre 10 13 657 660 B-treatment
- 13 14 660 661 I-treatment
treatment 14 23 661 670 I-treatment
) 23 24 670 671 O
serum 25 30 672 677 B-clinical_variable
troponin 31 39 678 686 I-clinical_variable
T 40 41 687 688 I-clinical_variable
( 42 43 689 690 I-clinical_variable
TnT 43 46 690 693 I-clinical_variable
) 46 47 693 694 I-clinical_variable
≥ 48 49 695 696 O
0.03 50 54 697 701 B-lower_bound
ng 55 57 702 704 I-lower_bound
/ 57 58 704 705 I-lower_bound
mL 58 60 705 707 I-lower_bound

Baseline 0 8 708 716 O
fasting 9 16 717 724 O
triglycerides 17 30 725 738 B-clinical_variable
> 31 32 739 740 O
2.5 33 36 741 744 B-lower_bound
institutional 37 50 745 758 I-lower_bound
upper 51 56 759 764 I-lower_bound
limit 57 62 765 770 I-lower_bound
of 63 65 771 773 I-lower_bound
normal 66 72 774 780 I-lower_bound
( 73 74 781 782 I-lower_bound
IULN 74 78 782 786 I-lower_bound
) 78 79 786 787 I-lower_bound
or 80 82 788 790 O
hypertriglyceridemia 83 103 791 811 B-chronic_disease
requiring 104 113 812 821 O
medication 114 124 822 832 B-treatment

Concomitant 0 11 833 844 O
use 12 15 845 848 O
of 16 18 849 851 O
the 19 22 852 855 O
following 23 32 856 865 O
drugs 33 38 866 871 O
( 39 40 872 873 O
see 40 43 873 876 O
Concomitant 44 55 877 888 O
Medications 56 67 889 900 O
, 67 68 900 901 O
Section 69 76 902 909 O
3.3 77 80 910 913 O
): 80 82 913 915 O
antioxidants 83 95 916 928 B-treatment
; 95 96 928 929 O
herbal 97 103 930 936 B-treatment
or 104 106 937 939 I-treatment
other 107 112 940 945 I-treatment
alternative 113 124 946 957 I-treatment
therapy 125 132 958 965 I-treatment
medications 133 144 966 977 I-treatment
; 144 145 977 978 O
vitamin 146 153 979 986 B-treatment
supplements 154 165 987 998 I-treatment
( 166 167 999 1000 O
especially 167 177 1000 1010 O
vitamins 178 186 1011 1019 B-treatment
A 187 188 1020 1021 I-treatment
, 188 189 1021 1022 I-treatment
C 190 191 1023 1024 I-treatment
, 191 192 1024 1025 I-treatment
and 193 196 1026 1029 I-treatment
E 197 198 1030 1031 I-treatment
) 198 199 1031 1032 O
other 200 205 1033 1038 O
than 206 210 1039 1043 O
a 211 212 1044 1045 O
standard 213 221 1046 1054 O
dose 222 226 1055 1059 O
multivitamin 227 239 1060 1072 B-treatment
, 239 240 1072 1073 O
acetaminophen 241 254 1074 1087 B-treatment
, 254 255 1087 1088 O
cyclosporine 256 268 1089 1101 B-treatment
A 269 270 1102 1103 I-treatment
or 271 273 1104 1106 O
analogue 274 282 1107 1115 O
; 282 283 1115 1116 O
verapamil 284 293 1117 1126 B-treatment
; 293 294 1126 1127 O
tamoxifen 295 304 1128 1137 B-treatment
or 305 307 1138 1140 O
analogue 308 316 1141 1149 O
, 316 317 1149 1150 O
ketoconazole 318 330 1151 1163 B-treatment
, 330 331 1163 1164 O
chlorpromazine 332 346 1165 1179 B-treatment
; 346 347 1179 1180 O
RU486 348 353 1181 1186 B-treatment
; 353 354 1186 1187 O
indomethacin 355 367 1188 1200 B-treatment
; 367 368 1200 1201 O
or 369 371 1202 1204 O
sulfinpyrazone 372 386 1205 1219 B-treatment
, 386 387 1219 1220 O
tetracycline 388 400 1221 1233 B-treatment
, 400 401 1233 1234 O
nalidixic 402 411 1235 1244 B-treatment
acid 412 416 1245 1249 I-treatment
, 416 417 1249 1250 O
nitrofurantoin 418 432 1251 1265 B-treatment
, 432 433 1265 1266 O
phenytoin 434 443 1267 1276 B-treatment
, 443 444 1276 1277 O
sulfonamides 445 457 1278 1290 B-treatment
, 457 458 1290 1291 O
lithium 459 466 1292 1299 B-treatment
, 466 467 1299 1300 O
ceftriaxone 468 479 1301 1312 B-treatment
, 479 480 1312 1313 O
and 481 484 1314 1317 O
amiodarone 485 495 1318 1328 B-treatment

ECOG 0 4 1329 1333 B-clinical_variable
performance 5 16 1334 1345 I-clinical_variable
status 17 23 1346 1352 I-clinical_variable
of 24 26 1353 1355 O
0 27 28 1356 1357 B-lower_bound
- 29 30 1358 1359 O
2 31 32 1360 1361 B-upper_bound

ECOG 0 4 1362 1366 B-clinical_variable
performance 5 16 1367 1378 I-clinical_variable
status 17 23 1379 1385 I-clinical_variable
of 24 26 1386 1388 O
0 27 28 1389 1390 B-lower_bound
- 29 30 1391 1392 O
2 31 32 1393 1394 B-upper_bound
and 33 36 1395 1398 O
estimated 37 46 1399 1408 O
survival 47 55 1409 1417 O
of 56 58 1418 1420 O
at 59 61 1421 1423 O
least 62 67 1424 1429 O
3 68 69 1430 1431 B-upper_bound
months 70 76 1432 1438 I-upper_bound

Effects 0 7 1439 1446 O
of 8 10 1447 1449 O
fenretinide 11 22 1450 1461 B-treatment
and 23 26 1462 1465 O
safingol 27 35 1466 1474 B-treatment
on 36 38 1475 1477 O
the 39 42 1478 1481 O
developing 43 53 1482 1492 O
human 54 59 1493 1498 O
fetus 60 65 1499 1504 O
are 66 69 1505 1508 O
unknown 70 77 1509 1516 O

For 0 3 1517 1520 O
women 4 9 1521 1526 B-gender
of 10 12 1527 1529 O
child 13 18 1530 1535 O
- 18 19 1535 1536 O
bearing 19 26 1536 1543 O
potential 27 36 1544 1553 O
, 36 37 1553 1554 O
a 38 39 1555 1556 O
negative 40 48 1557 1565 B-pregnancy
serum 49 54 1566 1571 I-pregnancy
pregnancy 55 64 1572 1581 I-pregnancy
test 65 69 1582 1586 O
is 70 72 1587 1589 O
required 73 81 1590 1598 O
within 82 88 1599 1605 O
72 89 91 1606 1608 B-upper_bound
hours 92 97 1609 1614 I-upper_bound
prior 98 103 1615 1620 I-upper_bound
to 104 106 1621 1623 O
receiving 107 116 1624 1633 O
study 117 122 1634 1639 B-treatment
drug 123 127 1640 1644 I-treatment
each 128 132 1645 1649 O
cycle 133 138 1650 1655 O

For 0 3 1656 1659 O
women 4 9 1660 1665 B-gender
of 10 12 1666 1668 O
child 13 18 1669 1674 O
- 18 19 1674 1675 O
bearing 19 26 1675 1682 O
potential 27 36 1683 1692 O
, 36 37 1692 1693 O
a 38 39 1694 1695 O
negative 40 48 1696 1704 B-pregnancy
serum 49 54 1705 1710 I-pregnancy
pregnancy 55 64 1711 1720 I-pregnancy
test 65 69 1721 1725 O
is 70 72 1726 1728 O
required 73 81 1729 1737 O
within 82 88 1738 1744 O
72hours 89 96 1745 1752 B-upper_bound
prior 97 102 1753 1758 I-upper_bound
to 103 105 1759 1761 O
receiving 106 115 1762 1771 O
study 116 121 1772 1777 O
drug 122 126 1778 1782 O
each 127 131 1783 1787 O
cycle 132 137 1788 1793 O

Hemoglobin 0 10 1794 1804 B-clinical_variable
≥ 11 12 1805 1806 O
8.0 13 16 1807 1810 B-lower_bound
gm 17 19 1811 1813 I-lower_bound
/ 19 20 1813 1814 I-lower_bound
dL 20 22 1814 1816 I-lower_bound
; 22 23 1816 1817 O
transfusion 24 35 1818 1829 B-treatment
permitted 36 45 1830 1839 O
to 46 48 1840 1842 O
achieve 49 56 1843 1850 O
this 57 61 1851 1855 O
level 62 67 1856 1861 O

Karnofsky 0 9 1862 1871 B-clinical_variable
> 10 11 1872 1873 O
60 12 14 1874 1876 B-lower_bound
% 14 15 1876 1877 I-lower_bound

Known 0 5 1878 1883 O
allergy 6 13 1884 1891 O
to 14 16 1892 1894 O
egg 17 20 1895 1898 B-allergy_name
products 21 29 1899 1907 I-allergy_name
or 30 32 1908 1910 O
soy 33 36 1911 1914 B-allergy_name
bean 37 41 1915 1919 I-allergy_name
oil 42 45 1920 1923 I-allergy_name

Known 0 5 1924 1929 O
history 6 13 1930 1937 O
of 14 16 1938 1940 O
allergic 17 25 1941 1949 O
reactions 26 35 1950 1959 O
attributed 36 46 1960 1970 O
to 47 49 1971 1973 O
compounds 50 59 1974 1983 B-allergy_name
of 60 62 1984 1986 I-allergy_name
similar 63 70 1987 1994 I-allergy_name
chemical 71 79 1995 2003 I-allergy_name
or 80 82 2004 2006 I-allergy_name
biologic 83 91 2007 2015 I-allergy_name
composition 92 103 2016 2027 I-allergy_name
to 104 106 2028 2030 I-allergy_name
fenretinide 107 118 2031 2042 I-allergy_name
, 118 119 2042 2043 O
such 120 124 2044 2048 O
as 125 127 2049 2051 O
13 128 130 2052 2054 B-allergy_name
- 130 131 2054 2055 I-allergy_name
cis 131 134 2055 2058 I-allergy_name
- 134 135 2058 2059 I-allergy_name
retinoic 135 143 2059 2067 I-allergy_name
acid 144 148 2068 2072 I-allergy_name
, 148 149 2072 2073 O
retinol 150 157 2074 2081 B-allergy_name
, 157 158 2081 2082 O
or 159 161 2083 2085 O
all 162 165 2086 2089 B-allergy_name
- 165 166 2089 2090 I-allergy_name
trans 166 171 2090 2095 I-allergy_name
- 171 172 2095 2096 I-allergy_name
retinoic 172 180 2096 2104 I-allergy_name
acid 181 185 2105 2109 I-allergy_name

Life 0 4 2110 2114 B-clinical_variable
expectancy 5 15 2115 2125 I-clinical_variable
of 16 18 2126 2128 O
greater 19 26 2129 2136 O
than 27 31 2137 2141 O
3 32 33 2142 2143 B-lower_bound
months 34 40 2144 2150 I-lower_bound

Major 0 5 2151 2156 B-treatment
surgery 6 13 2157 2164 I-treatment
in 14 16 2165 2167 O
the 17 20 2168 2171 O
last 21 25 2172 2176 B-upper_bound
three 26 31 2177 2182 I-upper_bound
weeks 32 37 2183 2188 I-upper_bound
due 38 41 2189 2192 O
to 42 44 2193 2195 O
unknown 45 52 2196 2203 O
effects 53 60 2204 2211 O
of 61 63 2212 2214 O
fenretinide 64 75 2215 2226 B-treatment
and 76 79 2227 2230 O
safingol 80 88 2231 2239 B-treatment
on 89 91 2240 2242 O
wound 92 97 2243 2248 O
healing 98 105 2249 2256 O

Patients 0 8 2257 2265 O
known 9 14 2266 2271 O
to 15 17 2272 2274 O
be 18 20 2275 2277 O
HIV 21 24 2278 2281 B-chronic_disease
- 24 25 2281 2282 O
positive 25 33 2282 2290 O
receiving 34 43 2291 2300 O
anti 44 48 2301 2305 B-treatment
- 48 49 2305 2306 I-treatment
retroviral 49 59 2306 2316 I-treatment
therapy 60 67 2317 2324 I-treatment
are 68 71 2325 2328 O
excluded 72 80 2329 2337 O
from 81 85 2338 2342 O
the 86 89 2343 2346 O
study 90 95 2347 2352 O
because 96 103 2353 2360 O
of 104 106 2361 2363 O
possible 107 115 2364 2372 O
pharmacokinetic 116 131 2373 2388 O
interactions 132 144 2389 2401 O

Patients 0 8 2402 2410 O
must 9 13 2411 2415 O
have 14 18 2416 2420 O
histologically 19 33 2421 2435 O
or 34 36 2436 2438 O
cytologically 37 50 2439 2452 O
confirmed 51 60 2453 2462 O
malignancy 61 71 2463 2473 B-cancer
that 72 76 2474 2478 O
is 77 79 2479 2481 O
metastatic 80 90 2482 2492 O
or 91 93 2493 2495 O
unresectable 94 106 2496 2508 O
and 107 110 2509 2512 O
for 111 114 2513 2516 O
which 115 120 2517 2522 O
standard 121 129 2523 2531 O
curative 130 138 2532 2540 B-treatment
or 139 141 2541 2543 O
palliative 142 152 2544 2554 B-treatment
measures 153 161 2555 2563 I-treatment
do 162 164 2564 2566 O
not 165 168 2567 2570 O
exist 169 174 2571 2576 O
or 175 177 2577 2579 O
are 178 181 2580 2583 O
no 182 184 2584 2586 O
longer 185 191 2587 2593 O
effective 192 201 2594 2603 O

Patients 0 8 2604 2612 O
must 9 13 2613 2617 O
have 14 18 2618 2622 O
histologically 19 33 2623 2637 O
or 34 36 2638 2640 O
cytologically 37 50 2641 2654 O
confirmed 51 60 2655 2664 O
non 61 64 2665 2668 B-cancer
- 64 65 2668 2669 I-cancer
Hodgkin 65 72 2669 2676 I-cancer
's 72 74 2676 2678 I-cancer
lymphoma 75 83 2679 2687 I-cancer
for 84 87 2688 2691 O
which 88 93 2692 2697 O
standard 94 102 2698 2706 B-treatment
therapies 103 112 2707 2716 I-treatment
do 113 115 2717 2719 O
not 116 119 2720 2723 O
exist 120 125 2724 2729 O
or 126 128 2730 2732 O
are 129 132 2733 2736 O
no 133 135 2737 2739 O
longer 136 142 2740 2746 O
effective 143 152 2747 2756 O

Patients 0 8 2757 2765 O
must 9 13 2766 2770 O
have 14 18 2771 2775 O
recovered 19 28 2776 2785 O
from 29 33 2786 2790 O
toxicities 34 44 2791 2801 O
of 45 47 2802 2804 O
prior 48 53 2805 2810 B-treatment
therapy 54 61 2811 2818 I-treatment

Patients 0 8 2819 2827 O
requiring 9 18 2828 2837 O
medication 19 29 2838 2848 B-treatment
for 30 33 2849 2852 O
other 34 39 2853 2858 O
dyslipidemias 40 53 2859 2872 B-chronic_disease
( 54 55 2873 2874 O
i.e. 55 59 2874 2878 O
, 59 60 2878 2879 O
elevated 61 69 2880 2888 O
LDL 70 73 2889 2892 B-clinical_variable
cholesterol 74 85 2893 2904 I-clinical_variable
) 85 86 2904 2905 O

Patients 0 8 2906 2914 O
who 9 12 2915 2918 O
have 13 17 2919 2923 O
received 18 26 2924 2932 O
prior 27 32 2933 2938 B-treatment
treatment 33 42 2939 2948 I-treatment
with 43 47 2949 2953 O
oral 48 52 2954 2958 B-treatment
or 53 55 2959 2961 I-treatment
intravenous 56 67 2962 2973 I-treatment
fenretinide 68 79 2974 2985 I-treatment
as 80 82 2986 2988 O
a 83 84 2989 2990 O
single 85 91 2991 2997 O
agent 92 97 2998 3003 O
are 98 101 3004 3007 O
eligible 102 110 3008 3016 O
, 110 111 3016 3017 O
provided 112 120 3018 3026 O
they 121 125 3027 3031 O
did 126 129 3032 3035 O
not 130 133 3036 3039 O
experience 134 144 3040 3050 O
severe 145 151 3051 3057 O
toxicity 152 160 3058 3066 O
related 161 168 3067 3074 O
to 169 171 3075 3077 O
fenretinide 172 183 3078 3089 O

Patients 0 8 3090 3098 O
with 9 13 3099 3103 O
an 14 16 3104 3106 O
identified 17 27 3107 3117 O
familial 28 36 3118 3126 B-chronic_disease
hyperlipidemia 37 51 3127 3141 I-chronic_disease
disorder 52 60 3142 3150 I-chronic_disease

Patients 0 8 3151 3159 O
with 9 13 3160 3164 O
esophageal 14 24 3165 3175 B-cancer
cancer 25 31 3176 3182 I-cancer
with 32 36 3183 3187 O
unresected 37 47 3188 3198 O
or 48 50 3199 3201 O
recurrent 51 60 3202 3211 O
primary 61 68 3212 3219 B-cancer
tumors 69 75 3220 3226 I-cancer
in 76 78 3227 3229 O
the 79 82 3230 3233 O
esophagus 83 92 3234 3243 O
are 93 96 3244 3247 O
only 97 101 3248 3252 O
permitted 102 111 3253 3262 O
after 112 117 3263 3268 O
discussion 118 128 3269 3279 O
of 129 131 3280 3282 O
patient 132 139 3283 3290 O
with 140 144 3291 3295 O
Study 145 150 3296 3301 O
Chair 151 156 3302 3307 O
due 157 160 3308 3311 O
to 161 163 3312 3314 O
concern 164 171 3315 3322 O
of 172 174 3323 3325 O
tumor 175 180 3326 3331 B-treatment
necrosis 181 189 3332 3340 I-treatment
and 190 193 3341 3344 O
esophageal 194 204 3345 3355 B-treatment
perforation 205 216 3356 3367 I-treatment

Patients 0 8 3368 3376 O
with 9 13 3377 3381 O
previously 14 24 3382 3392 O
untreated 25 34 3393 3402 O
brain 35 40 3403 3408 B-cancer
metastases 41 51 3409 3419 I-cancer
( 52 53 3420 3421 O
including 53 62 3421 3430 O
parenchymal 63 74 3431 3442 B-chronic_disease
, 74 75 3442 3443 O
meningeal 76 85 3444 3453 B-chronic_disease
or 86 88 3454 3456 O
dural 89 94 3457 3462 B-chronic_disease
- 94 95 3462 3463 I-chronic_disease
based 95 100 3463 3468 I-chronic_disease
CNS 101 104 3469 3472 I-chronic_disease
lesions 105 112 3473 3480 I-chronic_disease
) 112 113 3480 3481 O

Poorly 0 6 3482 3488 O
- 6 7 3488 3489 O
controlled 7 17 3489 3499 O
diabetes 18 26 3500 3508 B-chronic_disease
mellitus 27 35 3509 3517 I-chronic_disease
, 35 36 3517 3518 O
as 37 39 3519 3521 O
defined 40 47 3522 3529 O
as 48 50 3530 3532 O
fasting 51 58 3533 3540 B-clinical_variable
serum 59 64 3541 3546 I-clinical_variable
glucose 65 72 3547 3554 I-clinical_variable
concentration 73 86 3555 3568 I-clinical_variable
over 87 91 3569 3573 O
200 92 95 3574 3577 B-lower_bound
mg 96 98 3578 3580 I-lower_bound
/ 98 99 3580 3581 I-lower_bound
dl 99 101 3581 3583 I-lower_bound
or 102 104 3584 3586 O
a 105 106 3587 3588 O
hemoglobin 107 117 3589 3599 B-clinical_variable
A1C 118 121 3600 3603 I-clinical_variable
over 122 126 3604 3608 O
7.5 127 130 3609 3612 B-lower_bound
% 130 131 3612 3613 I-lower_bound

Pregnant 0 8 3614 3622 B-pregnancy
women 9 14 3623 3628 B-gender
are 15 18 3629 3632 O
excluded 19 27 3633 3641 O
from 28 32 3642 3646 O
this 33 37 3647 3651 O
study 38 43 3652 3657 O
because 44 51 3658 3665 O
the 52 55 3666 3669 O
effects 56 63 3670 3677 O
of 64 66 3678 3680 O
fenretinide 67 78 3681 3692 B-treatment
and 79 82 3693 3696 O
safingol 83 91 3697 3705 B-treatment
on 92 94 3706 3708 O
the 95 98 3709 3712 O
developing 99 109 3713 3723 O
human 110 115 3724 3729 O
fetus 116 121 3730 3735 O
are 122 125 3736 3739 O
unknown 126 133 3740 3747 O

Radiation 0 9 3748 3757 B-treatment
therapy 10 17 3758 3765 I-treatment
, 17 18 3765 3766 O
chemotherapy 19 31 3767 3779 B-treatment
, 31 32 3779 3780 O
and 33 36 3781 3784 O
other 37 42 3785 3790 O
investigational 43 58 3791 3806 O
agents 59 65 3807 3813 O
within 66 72 3814 3820 O
3weeks 73 79 3821 3827 B-upper_bound
( 80 81 3828 3829 O
6 81 82 3829 3830 B-upper_bound
weeks 83 88 3831 3836 I-upper_bound
for 89 92 3837 3840 O
nitrosourea 93 104 3841 3852 B-treatment
or 105 107 3853 3855 O
mitomycin 108 117 3856 3865 B-treatment
C 118 119 3866 3867 I-treatment
) 119 120 3867 3868 O
prior 121 126 3869 3874 O
to 127 129 3875 3877 O
starting 130 138 3878 3886 O
fenretinide 139 150 3887 3898 B-treatment
+ 151 152 3899 3900 O
safingol 153 161 3901 3909 B-treatment

Serum 0 5 3910 3915 B-clinical_variable
creatinine 6 16 3916 3926 I-clinical_variable
≤ 17 18 3927 3928 O
1.5 19 22 3929 3932 B-upper_bound
x 23 24 3933 3934 I-upper_bound
the 25 28 3935 3938 I-upper_bound
upper 29 34 3939 3944 I-upper_bound
limits 35 41 3945 3951 I-upper_bound
of 42 44 3952 3954 I-upper_bound
institutional 45 58 3955 3968 I-upper_bound
normal 59 65 3969 3975 I-upper_bound
( 66 67 3976 3977 I-upper_bound
IULN 67 71 3977 3981 I-upper_bound
) 71 72 3981 3982 I-upper_bound

Should 0 6 3983 3989 O
a 7 8 3990 3991 O
woman 9 14 3992 3997 B-gender
become 15 21 3998 4004 O
pregnant 22 30 4005 4013 B-pregnancy
or 31 33 4014 4016 O
suspect 34 41 4017 4024 O
she 42 45 4025 4028 O
is 46 48 4029 4031 O
pregnant 49 57 4032 4040 O
while 58 63 4041 4046 O
participating 64 77 4047 4060 O
in 78 80 4061 4063 O
this 81 85 4064 4068 O
study 86 91 4069 4074 O
, 91 92 4074 4075 O
she 93 96 4076 4079 O
should 97 103 4080 4086 O
inform 104 110 4087 4093 O
her 111 114 4094 4097 O
treating 115 123 4098 4106 O
physician 124 133 4107 4116 O
immediately 134 145 4117 4128 O

Should 0 6 4129 4135 O
a 7 8 4136 4137 O
woman 9 14 4138 4143 B-gender
become 15 21 4144 4150 B-pregnancy
pregnant 22 30 4151 4159 I-pregnancy
or 31 33 4160 4162 O
suspect 34 41 4163 4170 O
she 42 45 4171 4174 O
is 46 48 4175 4177 O
pregnant 49 57 4178 4186 O
while 58 63 4187 4192 O
she 64 67 4193 4196 O
or 68 70 4197 4199 O
her 71 74 4200 4203 O
partner 75 82 4204 4211 O
is 83 85 4212 4214 O
participating 86 99 4215 4228 O
in 100 102 4229 4231 O
this 103 107 4232 4236 O
study 108 113 4237 4242 O
, 113 114 4242 4243 O
she 115 118 4244 4247 O
should 119 125 4248 4254 O
inform 126 132 4255 4261 O
her 133 136 4262 4265 O
treating 137 145 4266 4274 O
physician 146 155 4275 4284 O
immediately 156 167 4285 4296 O

The 0 3 4297 4300 O
effects 4 11 4301 4308 O
of 12 14 4309 4311 O
fenretinide 15 26 4312 4323 B-treatment
and 27 30 4324 4327 O
safingol 31 39 4328 4336 B-treatment
on 40 42 4337 4339 O
the 43 46 4340 4343 O
developing 47 57 4344 4354 O
human 58 63 4355 4360 O
fetus 64 69 4361 4366 O
are 70 73 4367 4370 O
unknown 74 81 4371 4378 O

Total 0 5 4379 4384 B-clinical_variable
bilirubin 6 15 4385 4394 I-clinical_variable
≤ 16 17 4395 4396 O
1.5 18 21 4397 4400 B-upper_bound
x 22 23 4401 4402 I-upper_bound
the 24 27 4403 4406 I-upper_bound
IULN 28 32 4407 4411 I-upper_bound

Uncontrolled 0 12 4412 4424 O
intercurrent 13 25 4425 4437 O
illnesses 26 35 4438 4447 O
including 36 45 4448 4457 O
, 45 46 4457 4458 O
but 47 50 4459 4462 O
not 51 54 4463 4466 O
limited 55 62 4467 4474 O
to 63 65 4475 4477 O
, 65 66 4477 4478 O
ongoing 67 74 4479 4486 O
or 75 77 4487 4489 O
active 78 84 4490 4496 O
systemic 85 93 4497 4505 B-chronic_disease
infection 94 103 4506 4515 I-chronic_disease
, 103 104 4515 4516 O
symptomatic 105 116 4517 4528 B-chronic_disease
congestive 117 127 4529 4539 I-chronic_disease
heart 128 133 4540 4545 I-chronic_disease
failure 134 141 4546 4553 I-chronic_disease
, 141 142 4553 4554 O
unstable 143 151 4555 4563 B-chronic_disease
angina 152 158 4564 4570 I-chronic_disease
pectoris 159 167 4571 4579 I-chronic_disease
, 167 168 4579 4580 O
cardiac 169 176 4581 4588 B-chronic_disease
arrhythmia 177 187 4589 4599 I-chronic_disease
, 187 188 4599 4600 O
coagulation 189 200 4601 4612 B-chronic_disease
disorders 201 210 4613 4622 I-chronic_disease

absolute 0 8 4623 4631 B-clinical_variable
neutrophil 9 19 4632 4642 I-clinical_variable
count 20 25 4643 4648 I-clinical_variable
≥ 26 27 4649 4650 O
1,500 28 33 4651 4656 B-lower_bound
/ 33 34 4656 4657 I-lower_bound
μL 34 36 4657 4659 I-lower_bound

creatinine 0 10 4660 4670 B-clinical_variable
clearance 11 20 4671 4680 I-clinical_variable
≥ 21 22 4681 4682 O
60 23 25 4683 4685 B-lower_bound
mL 26 28 4686 4688 I-lower_bound
/ 28 29 4688 4689 I-lower_bound
min/1.73 29 37 4689 4697 I-lower_bound
m2 38 40 4698 4700 I-lower_bound
for 41 44 4701 4704 O
patients 45 53 4705 4713 O
with 54 58 4714 4718 O
creatinine 59 69 4719 4729 O
levels 70 76 4730 4736 O
above 77 82 4737 4742 O
institutional 83 96 4743 4756 O
normal 97 103 4757 4763 O

creatinine 0 10 4764 4774 B-clinical_variable
within 11 17 4775 4781 O
institutional 18 31 4782 4795 O
normal 32 38 4796 4802 O
limits 39 45 4803 4809 O
( 46 47 4810 4811 O
WNL 47 50 4811 4814 O
) 50 51 4814 4815 O

lymphoma 0 8 4816 4824 B-cancer
patients 9 17 4825 4833 O
must 18 22 4834 4838 O
have 23 27 4839 4843 O
no 28 30 4844 4846 O
marrow 31 37 4847 4853 O
involvement 38 49 4854 4865 O
as 50 52 4866 4868 O
documented 53 63 4869 4879 O
by 64 66 4880 4882 O
routine 67 74 4883 4890 O
marrow 75 81 4891 4897 B-treatment
aspiration 82 92 4898 4908 I-treatment
and 93 96 4909 4912 O
biopsy 97 103 4913 4919 B-treatment
performed 104 113 4920 4929 O
within 114 120 4930 4936 O
30 121 123 4937 4939 B-upper_bound
days 124 128 4940 4944 I-upper_bound
of 129 131 4945 4947 O
study 132 137 4948 4953 O
entry 138 143 4954 4959 O

other 0 5 4960 4965 O
major 6 11 4966 4971 B-chronic_disease
medical 12 19 4972 4979 I-chronic_disease
illnesses 20 29 4980 4989 I-chronic_disease
of 30 32 4990 4992 O
the 33 36 4993 4996 O
cardiovascular 37 51 4997 5011 O
or 52 54 5012 5014 O
respiratory 55 66 5015 5026 O
systems 67 74 5027 5034 O
or 75 77 5035 5037 O
psychiatric 78 89 5038 5049 B-chronic_disease
illness 90 97 5050 5057 I-chronic_disease
/ 97 98 5057 5058 O
social 98 104 5058 5064 B-chronic_disease
situations 105 115 5065 5075 I-chronic_disease
that 116 120 5076 5080 O
would 121 126 5081 5086 O
limit 127 132 5087 5092 O
compliance 133 143 5093 5103 O
with 144 148 5104 5108 O
study 149 154 5109 5114 O
requirements 155 167 5115 5127 O

patients 0 8 5128 5136 O
with 9 13 5137 5141 O
previously 14 24 5142 5152 O
treated 25 32 5153 5160 O
( 33 34 5161 5162 O
surgery 34 41 5162 5169 B-treatment
, 41 42 5169 5170 O
radiation 43 52 5171 5180 B-treatment
or 53 55 5181 5183 O
both 56 60 5184 5188 O
) 60 61 5188 5189 O
, 61 62 5189 5190 O
clinically 63 73 5191 5201 O
inactive 74 82 5202 5210 O
brain 83 88 5211 5216 B-cancer
metastases 89 99 5217 5227 I-cancer
, 99 100 5227 5228 O
who 101 104 5229 5232 O
have 105 109 5233 5237 O
not 110 113 5238 5241 O
received 114 122 5242 5250 O
corticosteroid 123 137 5251 5265 B-treatment
therapy 138 145 5266 5273 I-treatment
within 146 152 5274 5280 O
three 153 158 5281 5286 B-upper_bound
weeks 159 164 5287 5292 I-upper_bound
of 165 167 5293 5295 O
starting 168 176 5296 5304 O
protocol 177 185 5305 5313 B-treatment
therapy 186 193 5314 5321 I-treatment

platelets 0 9 5322 5331 B-clinical_variable
≥ 10 11 5332 5333 O
100,000 12 19 5334 5341 B-lower_bound
/ 19 20 5341 5342 I-lower_bound
μL 20 22 5342 5344 I-lower_bound

significant 0 11 5345 5356 O
ST 12 14 5357 5359 B-clinical_variable
depression 15 25 5360 5370 I-clinical_variable
( 26 27 5371 5372 O
ST 27 29 5372 5374 O
depression 30 40 5375 5385 O
of 41 43 5386 5388 O
≥2 44 46 5389 5391 O
mm 47 49 5392 5394 I-lower_bound
, 49 50 5394 5395 O
measured 51 59 5396 5404 O
from 60 64 5405 5409 O
isoelectric 65 76 5410 5421 O
line 77 81 5422 5426 O
to 82 84 5427 5429 O
the 85 88 5430 5433 O
ST 89 91 5434 5436 O
segment 92 99 5437 5444 O
at 100 102 5445 5447 O
a 103 104 5448 5449 O
point 105 110 5450 5455 O
60 111 113 5456 5458 O
msec 114 118 5459 5463 O
from 119 123 5464 5468 O
the 124 127 5469 5472 O
end 128 131 5473 5476 O
of 132 134 5477 5479 O
the 135 138 5480 5483 O
QRS 139 142 5484 5487 O
complex 143 150 5488 5495 O
) 150 151 5495 5496 O

significant 0 11 5497 5508 O
ST 12 14 5509 5511 B-clinical_variable
elevation 15 24 5512 5521 I-clinical_variable
( 25 26 5522 5523 O
> 26 27 5523 5524 O
1 28 29 5525 5526 B-lower_bound
mm 29 31 5526 5528 I-lower_bound
in 32 34 5529 5531 O
limb 35 39 5532 5536 B-clinical_variable
lead 40 44 5537 5541 I-clinical_variable
or 45 47 5542 5544 O
2 48 49 5545 5546 B-lower_bound
mm 50 52 5547 5549 I-lower_bound
in 53 55 5550 5552 O
precordial 56 66 5553 5563 B-clinical_variable
lead 67 71 5564 5568 I-clinical_variable
measured 72 80 5569 5577 O
at 81 83 5578 5580 O
a 84 85 5581 5582 O
point 86 91 5583 5588 O
0.04 92 96 5589 5593 O
sec 97 100 5594 5597 O
( 101 102 5598 5599 O
1 102 103 5599 5600 O
mm 104 106 5601 5603 O
) 106 107 5603 5604 O
after 108 113 5605 5610 O
the 114 117 5611 5614 O
J 118 119 5615 5616 O
- 119 120 5616 5617 O
point 120 125 5617 5622 O
[ 126 127 5623 5624 O
the 127 130 5624 5627 O
end 131 134 5628 5631 O
of 135 137 5632 5634 O
the 138 141 5635 5638 O
QRS 142 145 5639 5642 O
complex 146 153 5643 5650 O
] 153 154 5650 5651 O
and 155 158 5652 5655 O
compared 159 167 5656 5664 O
to 168 170 5665 5667 O
baseline 171 179 5668 5676 O
[ 180 181 5677 5678 O
line 181 185 5678 5682 O
drawn 186 191 5683 5688 O
from 192 196 5689 5693 O
P 197 198 5694 5695 O
start 199 204 5696 5701 O
to 205 207 5702 5704 O
T 208 209 5705 5706 O
end 210 213 5707 5710 O
] 213 214 5710 5711 O
) 214 215 5711 5712 O

total 0 5 5713 5718 O
bilirubin 6 15 5719 5728 B-clinical_variable
≤ 16 17 5729 5730 O
1.5 18 21 5731 5734 B-upper_bound
x 22 23 5735 5736 I-upper_bound
institutional 24 37 5737 5750 B-clinical_variable
upper 38 43 5751 5756 I-clinical_variable
limit 44 49 5757 5762 I-clinical_variable
of 50 52 5763 5765 I-clinical_variable
normal 53 59 5766 5772 I-clinical_variable
( 60 61 5773 5774 I-clinical_variable
IULN 61 65 5774 5778 I-clinical_variable
) 65 66 5778 5779 I-clinical_variable

women 0 5 5780 5785 B-gender
of 6 8 5786 5788 O
child 9 14 5789 5794 O
- 14 15 5794 5795 O
bearing 15 22 5795 5802 O
potential 23 32 5803 5812 O
and 33 36 5813 5816 O
men 37 40 5817 5820 O
must 41 45 5821 5825 O
agree 46 51 5826 5831 B-contraception_consent
to 52 54 5832 5834 I-contraception_consent
use 55 58 5835 5838 I-contraception_consent
adequate 59 67 5839 5847 I-contraception_consent
contraception 68 81 5848 5861 I-contraception_consent
( 82 83 5862 5863 O
hormonal 83 91 5863 5871 O
or 92 94 5872 5874 O
barrier 95 102 5875 5882 O
method 103 109 5883 5889 O
of 110 112 5890 5892 O
birth 113 118 5893 5898 O
control 119 126 5899 5906 O
) 126 127 5906 5907 O
prior 128 133 5908 5913 O
to 134 136 5914 5916 O
study 137 142 5917 5922 O
entry 143 148 5923 5928 O
, 148 149 5928 5929 O
for 150 153 5930 5933 O
the 154 157 5934 5937 O
duration 158 166 5938 5946 O
of 167 169 5947 5949 O
study 170 175 5950 5955 O
, 175 176 5955 5956 O
and 177 180 5957 5960 O
for 181 184 5961 5964 O
two 185 188 5965 5968 B-lower_bound
months 189 195 5969 5975 I-lower_bound
after 196 201 5976 5981 O
study 202 207 5982 5987 O
participation 208 221 5988 6001 O

women 0 5 6002 6007 B-gender
of 6 8 6008 6010 O
child 9 14 6011 6016 O
- 14 15 6016 6017 O
bearing 15 22 6017 6024 O
potential 23 32 6025 6034 O
and 33 36 6035 6038 O
men 37 40 6039 6042 O
must 41 45 6043 6047 O
agree 46 51 6048 6053 B-contraception_consent
to 52 54 6054 6056 I-contraception_consent
use 55 58 6057 6060 I-contraception_consent
adequate 59 67 6061 6069 I-contraception_consent
contraception 68 81 6070 6083 I-contraception_consent
( 82 83 6084 6085 O
hormonal 83 91 6085 6093 B-contraception_consent
or 92 94 6094 6096 I-contraception_consent
barrier 95 102 6097 6104 I-contraception_consent
method 103 109 6105 6111 I-contraception_consent
of 110 112 6112 6114 I-contraception_consent
birth 113 118 6115 6120 I-contraception_consent
control 119 126 6121 6128 I-contraception_consent
; 126 127 6128 6129 O
abstinence 128 138 6130 6140 B-contraception_consent
) 138 139 6140 6141 O
prior 140 145 6142 6147 O
to 146 148 6148 6150 O
study 149 154 6151 6156 O
entry 155 160 6157 6162 O
and 161 164 6163 6166 O
for 165 168 6167 6170 O
the 169 172 6171 6174 O
duration 173 181 6175 6183 O
of 182 184 6184 6186 O
study 185 190 6187 6192 O
participation 191 204 6193 6206 O

≤ 0 1 6207 6208 O
5 2 3 6209 6210 B-upper_bound
x 4 5 6211 6212 I-upper_bound
IULN 6 10 6213 6217 I-upper_bound
for 11 14 6218 6221 O
patients 15 23 6222 6230 O
with 24 28 6231 6235 O
liver 29 34 6236 6241 B-cancer
metastases 35 45 6242 6252 I-cancer

